UF Innovate’s Jim O’Connell Featured on Technology Transfer IP Podcast
Jim O’Connell, assistant vice president for Commercialization at UF Innovate is featured on Tech Transfer IP Forum Podcast, a space devoted to providing in-depth analysis of intellectual property issues related to university and non-profit technology transfer.
New Grant Will Help Develop Vaccine Delivery System for Tilapia Lake Virus
The Foundation for Food and Agriculture Research (FFAR) has joined in the war against the tilapia lake virus (TLV) with a US$ 790,326 (EUR 671,206) Seeding Solutions grant award to the University of Florida in support of the development of a vaccine delivery system for halting the spread of the disease.
Tampa Bay Company Searching for Other Vaccine Methods
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, is in the pre-clinical phase of developing a vaccine they say would solve two critical problems when it comes to ending the pandemic.
TearClear Moving Toward Clinical Trials and Strengthening Leadership Team
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, continues to make progress on the development of its first-in-class platform of preservative-free topical medications.
Everything You Need To Know About Vaccines and COVID-19
Dr. Peter Khoury, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), talked with James Di Virgilio, Radio Cade's host, about vaccinations and COVID-19.
Sid Martin Biotech Bids Long-Time Leader Merrie Shaw Goodbye
Merrie Shaw has made a tremendous impact on the economies of Alachua County and the state of Florida by helping companies find talent, funding, and partnerships.
Biotech Firm Raises $20 Million, Sees Progress on COVID-19 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc. has raised $20 million from the sale of common stock and will use some of the funding to boost its research into a Covid-19 vaccine.
Economic Impact
Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.
Tampa Company Developing Cancer Vaccines Could Receive Grant To Research Cervical Cancer Vaccine
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a Tampa-based company that has been researching and developing a vaccine for certain types of skin cancers, could be soon receiving a grant to begin research on a cervical cancer treatment for underprivileged women.
SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.
